Fed judge considers if pharmacies must sell Plan B

February 2, 2012 By GENE JOHNSON , Associated Press in Medications

(AP) -- A federal judge is considering whether Washington state can require pharmacies to stock and sell Plan B or other emergency contraceptives, even in the face of religious objections by druggists who believe they destroy human life.

U.S. Ronald Leighton heard closing arguments Wednesday in a lawsuit that claims state rules violate the of pharmacists by requiring them to dispense such medicine. The state requires pharmacies to dispense any medication for which there is a community need and to stock a representative assortment of drugs needed by their patients.

Ralph's Thriftway in Olympia, Wash., and two licensed Washington pharmacists sued in 2007, saying that dispensing would infringe on their religious beliefs because it can prevent the implantation of a fertilized egg. The state says the requirements are legal because they apply neutrally to medicines and pharmacies, and that they promote a government interest - the timely delivery of medicine, including Plan B, which becomes less effective as time passes.

The judge blocked the state dispensing rule in 2007, finding that it would violate the plaintiffs' freedom of religion. But a 9th U.S. Circuit Court of Appeals panel overruled him, saying that he applied the wrong legal standard and that the rule appeared constitutional because it was neutral and did not directly target .

The appellate court sent the case back to Leighton, telling him to apply the correct standard. He held an 11-day trial to flesh out the matter, and in court Wednesday, he expressed little patience for the state's enforcement of the rules, which he said reminded him of the federal government's arbitrary enforcement of the now-repealed rule against gays serving openly in the military.

The issue is more important than many other freedom-of-religion cases, such as those concerning religious dress or other ceremonial matters, he said.

"The question of life and death is serious," he thundered at an attorney for the state. "It's not facial hair, it's not a burka. ... I do not know when life begins, but I will not denigrate somebody's view of when life begins."

Leighton said he would rule in a couple weeks, and that he intended to frame his opinion in a way that would encourage the 9th Circuit and the U.S. Supreme Court to address whether pharmacists have a due-process right to refuse to provide medicine that they believe can take a life.

"Somebody at higher pay and higher station will decide this issue," he said. "I'll tee it up."

Plan B had been at the center of the state's decision in 2007 to adopt the Washington Board of Pharmacy's dispensary requirements. The drug, which has a high dose of medicine found in birth-control pills, is effective in preventing pregnancy if a woman takes it within 72 hours of unprotected sex.

Individual pharmacists are allowed to pass a prescription to another druggist in the same store, provided the order is not delayed. But that leaves no option for a lone or a owner with religious objections to a particular drug.

The pharmacists "can violate their core and participate in the taking of a human life, or they can lose their license," lawyer Kristen Waggoner said during her closing argument.

The pharmacists argued they can easily and quickly refer customers to nearby drug stores willing to sell the drug, but women's rights groups said that may not be the case in rural areas. It might also be difficult for those with disabilities if their pharmacists decide not to dispense it for personal reasons, they said.

Waggoner noted business exemptions that allow pharmacies not to stock a drug, including low demand, high cost, insurance concerns, and security reasons in cases where stocking a drug such as the addictive painkiller oxycodone could increase risk of theft. If the state allows pharmacies not to stock a drug for non-religious reasons, it should also allow them not to stock a drug for religious ones, she argued.

Democratic Gov. Chris Gregoire, who supports the dispensary requirements, has rejected a compromise that would have allowed druggists to refer patients to other pharmacies for reasons of conscience.

A group that includes HIV patients has intervened in the case on the state's behalf, arguing that if pharmacies can refuse to dispense Plan B for religious reasons, some might also refuse to dispense AIDS medications, for example.

According to filings in the case, eight states have rules requiring pharmacists to dispense all drugs. But most of those don't require pharmacies to stock Plan B or similar drugs, so pharmacies in those states wouldn't be required to dispense them, the plaintiffs argue.

Waggoner noted that the state showed no interest in rigidly enforcing the rule until groups such as Planned Parenthood began filing complaints and sending test-shoppers and picketers to pharmacies to see if they would dispense Plan B. She said it indicated the state's true objective was to stamp out religious objection to the drug, an idea she called "repugnant to the Constitution."

Hospital pharmacies in the state do not fall under the rules, which govern retail, outpatient pharmacies, and they can refuse to dispense certain drugs for reasons of conscience. Catholic hospitals won't dispense Plan B except in cases of rape, Leighton noted.

That makes the state's argument about promoting access to the drug a "red herring," he said.

"The poor people who rely on emergency rooms don't get the so-called benefit of the rule," he said. "It's riddled with exceptions and holes. It's Swiss cheese."

The state's lawyers argued that exemptions to the rule increase the accessibility of drugs because it helps pharmacies stay competitive.

Plan B is kept behind the counter but is available without a prescription to anyone over 17. Federal regulators recently recommended that it be sold to anyone regardless of age, but the Obama administration overruled its own experts in December, outraging women's rights groups and many in the president's own party.

©2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

not rated yet  

Rank not rated yet
Related Stories
Relevant PhysicsForums posts

More news stories

Merck ends development of Parkinson's disease drug

(AP)—Merck & Co. says it is ending development of an experimental Parkinson's disease drug because the drug wasn't working.

Medications created 20 hours ago | popularity 1 / 5 (1) | comments 0

J&J expects 10-plus new drug applications by 2017

(AP)—Johnson & Johnson is developing what could eventually be game-changing treatments for depression and pain, and it's aiming to apply for approval of more than 10 new medicines by 2017, executives said Thursday during ...

Medications created 21 hours ago | popularity 5 / 5 (1) | comments 0

Experts favor US approval of Merck sleeping pill (Update)

An independent panel of experts on Wednesday recommended US approval of a new Merck sleeping pill called suvorexant, but expressed concerns over the highest dosage and risks of drowsy daytime driving.

Medications created May 22, 2013 | popularity not rated yet | comments 0

Glaxo, US partnering to develop new antibiotics

GlaxoSmithKline PLC says it's starting an unusual collaboration with the U.S. government to develop several antibiotics for both bioterrorism threats and bacterial infections resistant to current medicines.

Medications created May 22, 2013 | popularity not rated yet | comments 0

Study finds new pneumococcal vaccine appears to be as safe as previously used vaccine

The new 13-valent pneumococcal conjugate vaccine (PCV13) appears to be as safe as the previous version used prior to 2010, the 7-valent pneumococcal conjugate vaccine (PCV7), according to a Kaiser Permanente study published ...

Medications created May 22, 2013 | popularity not rated yet | comments 0


About one in four uninsured could be excluded from ACA

(HealthDay)—More than one in four of those eligible for new premium assistance tax credits under the Affordable Care Act (ACA) do not have a checking account and will not be able to receive premiums from ...

Comorbidities common with alopecia areata

(HealthDay)—Comorbid conditions often accompany alopecia areata, according to a study published online May 22 in JAMA Dermatology.

Pollen count apps for smartphones are nothing to sneeze at

Kate O'Reilly's spring allergy survival kit includes the usual stuff - nasal sprays, allergy pills and a box of tissues. This season, she's added a new weapon to her line of defense: an app on her smartphone.

Hormone levels may provide key to understanding psychological disorders in women

Women at a particular stage in their monthly menstrual cycle may be more vulnerable to some of the psychological side-effects associated with stressful experiences, according to a study from UCL.

Engineered cytomegalovirus protects monkeys from HIV equivalent

(Medical Xpress)—A new study by researchers in the US has shown that an ancient virus can be modified to help in the fight against the simian immunodeficiency virus SIV, which is the equivalent in monkeys ...

Going live: Immune cell activation in multiple sclerosis

Biological processes are generally based on events at the molecular and cellular level. To understand what happens in the course of infections, diseases or normal bodily functions, scientists would need to ...